Objective
The growing interest raised in olignucleotide-directed triple helix formations ('anti-gene strategy!) is due to their potential biological and therapeutical applications for controling gene expression at both transcriptional and replicational levels. The present project is aimed at developing new approaches to extend the range of double-stranded DNA recognition via oligonucleotide-directed triple helix formation. The ultimate goal is to apply 'antigene strategy' to any DNA target sequence with biological interest without sequence limitation as it is currently restricted to polypurine-polypyrimidine tracts. Syntheses of modified oligonucleotides containing triple helix-specific stabilizers are envisioned. Their abilities to form stable extended triple helices under physiological conditions will be evaluated. Results are expected in inhibition of gene expression in oncogenes and HIV viral genes.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- natural sciencesbiological sciencesgeneticsDNA
- medical and health scienceshealth sciencesinfectious diseasesRNA virusesHIV
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Topic(s)
Call for proposal
Data not availableFunding Scheme
RGI - Research grants (individual fellowships)Coordinator
75231 Paris
France